Literature DB >> 28417149

Clincal interpretation of the anti-tuberculosis drug concentrations in diabetic and non-diabetic tuberculosis patients.

Nilan T Jacob1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28417149     DOI： 10.1007/s00228-017-2244-0

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  5 in total

Review 1.  (2) Classification and diagnosis of diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2015-01       Impact factor: 19.112

2.  Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus.

Authors:  A K Hemanth Kumar; V Chandrasekaran; T Kannan; A Lakshmi Murali; J Lavanya; V Sudha; Soumya Swaminathan; Geetha Ramachandran
Journal:  Eur J Clin Pharmacol       Date:  2016-09-20       Impact factor: 2.953

3.  Isoniazid, rifampin, and pyrazinamide plasma concentrations in relation to treatment response in Indonesian pulmonary tuberculosis patients.

Authors:  Erlina Burhan; Carolien Ruesen; Rovina Ruslami; Arum Ginanjar; Hadiarto Mangunnegoro; Purwantyastuti Ascobat; Rogier Donders; Reinout van Crevel; Rob Aarnoutse
Journal:  Antimicrob Agents Chemother       Date:  2013-05-20       Impact factor: 5.191

Review 4.  Clinical pharmacokinetics of isoniazid.

Authors:  W W Weber; D W Hein
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

5.  The impact of diabetes on tuberculosis treatment outcomes: a systematic review.

Authors:  Meghan A Baker; Anthony D Harries; Christie Y Jeon; Jessica E Hart; Anil Kapur; Knut Lönnroth; Salah-Eddine Ottmani; Sunali D Goonesekera; Megan B Murray
Journal:  BMC Med       Date:  2011-07-01       Impact factor: 8.775
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.